JAN EMMANUEL D.

SERRANO BSN III-1

DRUG STUDY

DRUG MECHANISM OF INDICATIONS ADVERSE AND SIDE NURSING MONITORING

ACTION EFFECTS RESPONSIBILITIES PARAMETERS
CNS: dizziness,  Assess  Monitor daily
GENERIC NAME Inhibits sodium and Pleural effusion encephalopathy, weight, intake
Furosemide chloride headache, fluid and output
reabsorption in the insomnia, status ratios, and lung
BRAND NAME ascending loop of nervousness during sounds.
Lasix Henle, thus EENT: hearing loss,  Monitor BP
increasing renal CONTRAINDICATIONS tinnitus drug and Pulse rate
CLASSIFICATION excretion of CV: hypotension therapy. before and
Loop Diuretics sodium, chloride Anuria; hepatic coma GI: constipation,  Assess during
and water. and precoma, severe diarrhea, dry administration
DOSAGE hypokalemia &/or mouth, dyspepsia, patient  Monitor
40mg IV q12 hyponatremia, nausea, vomiting for any electrolytes,
hypovolemia w/ or DERM: s/s of the renal and
w/o hypotension; photosensitivity, hepatic
hypersensitivity to rashes adverse function,
furosemide or ENDO: effects. serum glucose,
sulfonamides. hyperglycemia F&E: and uric acid
dehydration, levels before
hypokalemia, and
hypomagnesemsia, periodically
hyponatremia, throughout
hypovolimia, therapy.
metabolic alkalosis
HEMA: Blood
dyscrasias
JAN EMMANUEL D. SERRANO BSN III-1

DRUG STUDY

DRUG MECHANISM OF INDICATIONS ADVERSE AND SIDE NURSING MONITORING

ACTION EFFECTS RESPONSIBILITIES PARAMETERS
 Monitor for fluid
 Advise to report overload and
GENERIC NAME Decreases viscosity Respiratory affections Nausea, Vomiting,
difficulty with signs of
N- Acetyl cysteine of respiratory tract characterized by thick Urticaria, mild clearing the
secretions and and viscous fever, hypotension, airway or any hyponatremia
other respiratory (i.e., changes in
BRAND NAME promote their hypersecretions wheezing, dyspnea,
distress. mental status).
Fluimucil removal by and stomatitis.  Advise to report  Monitor for S&S of
breaking disulfide CONTRAINDICATIONS nausea, as an aspiration of excess
CLASSIFICATION bonds. antiemetic may secretions, and for
be indicated. bronchospasm
Mucolytic  Have suction (unpredictable);
Hypersensitivity to
apparatus withhold drug and
Phenylketonuria immediately notify physician
DOSAGE
available. immediately if
600mg in ½ glass either occurs.
water OD  Monitor ABGs,
pulmonary functions
and pulse oximetry
as indicated.

 JAN EMMANUEL D. SERRANO BSN III-1

DRUG MECHANISM OF INDICATIONS ADVERSE AND SIDE NURSING MONITORING

ACTION EFFECTS RESPONSIBILITIES PARAMETERS
CHF, Hypertension Dizziness,Vertigo,  Monitor for
 Give medications with orthostatic
GENERIC NAME tinnitus,fatigue,Bra food to decrease hypotension
Carvedilol dycardia,orthostati orthostatic and provide
c,hypertension,Gas hypotension. safety
 Assess for signs of precautions
BRAND NAME tric hypersensitivity.  Monitor
Carvibloc pain,flatulence,con  Report signs and diabetic
CONTRAINDICATIONS stipation,diarrhea symptoms of the patient closely;
adverse effects. drug may mask
CLASSIFICATION hypoglycemia
Antihypertensive Decompensated CHF, or worsen
bronchial asthma, hyperglycemia.
 Monitor
DOSAGE heartblock patient for
6.25mg 1tab OD ,cardiogenic shock, signs of
hypersensitivity to hepatic
impairement.
carvedilol, pregnancy, 
lactation